Which hedge funds own OVID? OVID THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in OVID (OVID THERAPEUTICS INC) in their Q2 2026 13F filings, worth $34.0m in total. The largest holder by portfolio weight is RA Capital Management at 0.2% of its book. 1 manager opened a new position this quarter: D. E. Shaw & Co. 2 exited: Brevan Howard Capital Management, Marshall Wace.
6tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold OVID? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.2% | $28.2m | 10,500,968 | -2% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $5.2m | 1,945,727 | 47% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $283.8k | 105,500 | -90% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $69.9k | 26,000 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $99.2k | 36,877 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $86.9k | 32,295 | -98% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $225.9k |
| Marshall Wace | 0.0% | $2.0m |
How has hedge fund ownership of OVID changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $34.0m |
| Q1 2026 | 8 | $35.6m |
| Q4 2025 | 4 | $25.7m |
| Q3 2025 | 2 | $2.7m |
| Q2 2025 | 3 | $857.7k |
| Q1 2025 | 3 | $2.0m |
| Q4 2024 | 3 | $5.1m |
| Q3 2024 | 3 | $6.4m |
| Q2 2024 | 3 | $4.2m |
| Q1 2024 | 3 | $16.8m |
| Q4 2023 | 3 | $17.4m |
| Q3 2023 | 3 | $21.3m |
| Q2 2023 | 3 | $18.3m |
| Q1 2023 | 3 | $18.4m |
| Q4 2022 | 3 | $13.0m |
| Q3 2022 | 3 | $8.6m |
Counts every tracked manager that disclosed OVID in that quarter's filing, including managers that have since stopped filing.